Hinze, Claas H. http://orcid.org/0000-0001-9247-4729
Foell, Dirk http://orcid.org/0000-0002-1946-3916
Kessel, Christoph
Article History
Accepted: 28 September 2023
First Online: 3 November 2023
Competing interests
: C.H.H. has received travel support from Pfizer. D.F. has received speaker fees/honoraria from Chugai-Roche, Novartis and Swedish Orphan Biovitrum (SOBI), as well as research support from Novartis, Pfizer and SOBI, and the German Research Foundation (DFG, grant number FO 354/14-1). C.K. has received consulting fees from Novartis and SOBI, research support from Novartis, and support from the German Research Foundation (grant number KE 2026 1/3).